Sharing clinical trial data : maximizing benefits, minimizing risk /

Saved in:
Bibliographic Details
Imprint:Washington, D.C. : The National Academies Press, [2015]
Description:1 online resource (1 PDF file (xiv, 290 pages)) : illustrations
Language:English
Series:Online access: National Academy of Sciences National Academies Press.
Online access: NCBI NCBI Bookshelf.
Subject:Clinical trials -- Data processing.
HEALTH & FITNESS -- Holism.
HEALTH & FITNESS -- Reference.
MEDICAL -- Alternative Medicine.
MEDICAL -- Atlases.
MEDICAL -- Essays.
MEDICAL -- Family & General Practice.
MEDICAL -- Holistic Medicine.
MEDICAL -- Osteopathy.
Clinical trials -- Data processing.
Clinical Trials as Topic.
Information Dissemination.
Electronic books.
Electronic books.
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11241371
Hidden Bibliographic Details
Other authors / contributors:Institute of Medicine (U.S.). Committee on Strategies for Responsible Sharing of Clinical Trial Data, issuing body.
ISBN:9780309316293
0309316294
9780309316309
0309316308
9780309367325
Notes:Title from PDF title page.
Includes bibliographical references.
This study was supported by contracts between the National Academy of Sciences and the U.S. National Institutes of Health (HHSN263201200074I), U.S. Food and Drug Administration, AbbVie Inc., Amgen Inc., AstraZeneca Pharmaceuticals, Bayer, Biogen Idec, Bristol-Myers Squibb, Burroughs Wellcome Fund, Doris Duke Charitable Foundation, Eli Lilly and Company, EMD Serono, Genentech, GlaxoSmithKline, Johnson & Johnson, Medical Research Council (UK), Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk, Pfizer Inc., Sanofi-Aventis, Takeda, and The Wellcome Trust. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the organizations or agencies that provided support for the project.
Version viewed June 22, 2015.
Summary:Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge and benefits to be gained from the efforts of clinical trial participants and investigators. At the same time, sharing clinical trial data presents risks, burdens, and challenges. These include the need to protect the privacy and honor the consent of clinical trial participants; safeguard the legitimate economic interests of sponsors; and guard against invalid secondary analyses, which could undermine trust in clinical trials or otherwise harm public health. Sharing Clinical Trial Data presents activities and strategies for the responsible sharing of clinical trial data. With the goal of increasing scientific knowledge to lead to better therapies for patients, this book identifies guiding principles and makes recommendations to maximize the benefits and minimize risks. This report offers guidance on the types of clinical trial data available at different points in the process, the points in the process at which each type of data should be shared, methods for sharing data, what groups should have access to data, and future knowledge and infrastructure needs. Responsible sharing of clinical trial data will allow other investigators to replicate published findings and carry out additional analyses, strengthen the evidence base for regulatory and clinical decisions, and increase the scientific knowledge gained from investments by the funders of clinical trials. The recommendations of Sharing Clinical Trial Data will be useful both now and well into the future as improved sharing of data leads to a stronger evidence base for treatment. This book will be of interest to stakeholders across the spectrum of research--from funders, to researchers, to journals, to physicians, and ultimately, to patients.
Other form:Sharing Clinical Trial Data. Natl Academy Pr 2015 9780309316293
LEADER 07137cam a2200817 i 4500
001 11241371
005 20210426223607.3
006 m o d
007 cr cn|||||||||
008 150502s2015 dcua obt 000 0 eng
003 ICU
010 |a  2015934702 
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d COO  |d CUX  |d MMU  |d CUS  |d N$T  |d YDXCP  |d E7B  |d OCLCF  |d EBLCP  |d ICA  |d K6U  |d OCLCQ  |d AGLDB  |d OCLCO  |d PIFFA  |d FVL  |d ZCU  |d MERUC  |d NJR  |d U3W  |d OCLCA  |d BUF  |d STF  |d OCLCQ  |d VTS  |d ICG  |d VT2  |d OCLCQ  |d WYU  |d LVT  |d TKN  |d DKC  |d OCLCQ  |d NLM  |d OCLCO  |d UKAHL  |d OCLCO  |d OCLCA  |d AJS  |d OCLCO 
016 7 |a 101658936  |2 DNLM 
019 |a 961602367  |a 1021268812  |a 1066459823  |a 1081223305  |a 1228591030  |a 1229686382 
020 |a 9780309316293 
020 |a 0309316294 
020 |a 9780309316309 
020 |a 0309316308 
020 |z 9780309367325 
035 |a (OCoLC)904734999  |z (OCoLC)961602367  |z (OCoLC)1021268812  |z (OCoLC)1066459823  |z (OCoLC)1081223305  |z (OCoLC)1228591030  |z (OCoLC)1229686382 
042 |a pcc 
050 4 |a R853.D37 
060 0 0 |a 2015 F-273 
060 1 0 |a W 20.55.C5 
072 7 |a HEA  |x 012000  |2 bisacsh 
072 7 |a HEA  |x 020000  |2 bisacsh 
072 7 |a MED  |x 004000  |2 bisacsh 
072 7 |a MED  |x 101000  |2 bisacsh 
072 7 |a MED  |x 109000  |2 bisacsh 
072 7 |a MED  |x 029000  |2 bisacsh 
072 7 |a MED  |x 040000  |2 bisacsh 
072 7 |a MED  |x 092000  |2 bisacsh 
049 |a MAIN 
245 0 0 |a Sharing clinical trial data :  |b maximizing benefits, minimizing risk /  |c Committee on Strategies for Responsible Sharing of Clinical Trial Data, Board on Health Sciences Policy, Institute of Medicine. 
264 1 |a Washington, D.C. :  |b The National Academies Press,  |c [2015] 
300 |a 1 online resource (1 PDF file (xiv, 290 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Title from PDF title page. 
504 |a Includes bibliographical references. 
520 3 |a Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge and benefits to be gained from the efforts of clinical trial participants and investigators. At the same time, sharing clinical trial data presents risks, burdens, and challenges. These include the need to protect the privacy and honor the consent of clinical trial participants; safeguard the legitimate economic interests of sponsors; and guard against invalid secondary analyses, which could undermine trust in clinical trials or otherwise harm public health. Sharing Clinical Trial Data presents activities and strategies for the responsible sharing of clinical trial data. With the goal of increasing scientific knowledge to lead to better therapies for patients, this book identifies guiding principles and makes recommendations to maximize the benefits and minimize risks. This report offers guidance on the types of clinical trial data available at different points in the process, the points in the process at which each type of data should be shared, methods for sharing data, what groups should have access to data, and future knowledge and infrastructure needs. Responsible sharing of clinical trial data will allow other investigators to replicate published findings and carry out additional analyses, strengthen the evidence base for regulatory and clinical decisions, and increase the scientific knowledge gained from investments by the funders of clinical trials. The recommendations of Sharing Clinical Trial Data will be useful both now and well into the future as improved sharing of data leads to a stronger evidence base for treatment. This book will be of interest to stakeholders across the spectrum of research--from funders, to researchers, to journals, to physicians, and ultimately, to patients. 
536 |a This study was supported by contracts between the National Academy of Sciences and the U.S. National Institutes of Health (HHSN263201200074I), U.S. Food and Drug Administration, AbbVie Inc., Amgen Inc., AstraZeneca Pharmaceuticals, Bayer, Biogen Idec, Bristol-Myers Squibb, Burroughs Wellcome Fund, Doris Duke Charitable Foundation, Eli Lilly and Company, EMD Serono, Genentech, GlaxoSmithKline, Johnson & Johnson, Medical Research Council (UK), Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk, Pfizer Inc., Sanofi-Aventis, Takeda, and The Wellcome Trust. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the views of the organizations or agencies that provided support for the project. 
588 0 |a Version viewed June 22, 2015. 
505 0 |a Introduction -- Guiding principles for sharing clinical trial data -- The roles and responsibilities of stakeholders in the sharing of clinical trial data -- The clinical trial life cycle and when to share data -- Access to clinical trial data: governance -- The future of data sharing in a changing landscape -- Study approach -- Concepts and methods for de-identifying clinical trial data -- Legal discussion of risks to industry sponsors -- Clinical trial data sharing policies: top 12 pharmaceutical companies ranked by 2013 market capitalization. 
650 0 |a Clinical trials  |x Data processing. 
650 7 |a HEALTH & FITNESS  |x Holism.  |2 bisacsh 
650 7 |a HEALTH & FITNESS  |x Reference.  |2 bisacsh 
650 7 |a MEDICAL  |x Alternative Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Atlases.  |2 bisacsh 
650 7 |a MEDICAL  |x Essays.  |2 bisacsh 
650 7 |a MEDICAL  |x Family & General Practice.  |2 bisacsh 
650 7 |a MEDICAL  |x Holistic Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Osteopathy.  |2 bisacsh 
650 7 |a Clinical trials  |x Data processing.  |2 fast  |0 (OCoLC)fst00864430 
650 1 2 |a Clinical Trials as Topic.  |0 https://id.nlm.nih.gov/mesh/D002986 
650 2 2 |a Information Dissemination. 
655 0 |a Electronic books. 
655 4 |a Electronic books. 
710 2 |a Institute of Medicine (U.S.).  |b Committee on Strategies for Responsible Sharing of Clinical Trial Data,  |e issuing body.  |0 http://id.loc.gov/authorities/names/n2014187759 
776 0 8 |t Sharing Clinical Trial Data.  |d Natl Academy Pr 2015  |z 9780309316293  |w (DLC) 2015934702  |w (OCoLC)907097146 
830 0 |a Online access: National Academy of Sciences National Academies Press. 
830 0 |a Online access: NCBI NCBI Bookshelf. 
856 4 0 |u http://www.nap.edu/catalog.php?record_id=18998  |y National Academies Press 
856 4 0 |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=991085  |y eBooks on EBSCOhost 
903 |a HeVa 
929 |a oclccm 
999 f f |i 38b2b5fb-c54f-59d6-9f94-c9e2a10c0c48  |s 44596078-3481-580b-b9fa-78909ff3fb5b 
928 |t Library of Congress classification  |a R853.D37  |l Online  |c UC-FullText  |u http://www.nap.edu/catalog.php?record_id=18998  |z National Academies Press  |g ebooks  |i 12422888 
928 |t Library of Congress classification  |a R853.D37  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=991085  |z eBooks on EBSCOhost  |g ebooks  |i 12422889